These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29531533)

  • 1. Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.
    Grande S; Palma A; Ricci-Vitiani L; Luciani AM; Buccarelli M; Biffoni M; Molinari A; Calcabrini A; D'Amore E; Guidoni L; Pallini R; Viti V; Rosi A
    Stem Cells Int; 2018; 2018():3292704. PubMed ID: 29531533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments.
    Grande S; Palma A; Luciani AM; Anello P; Ricci-Vitiani L; Buccarelli M; D'Alessandris QG; Pallini R; Guidoni L; Viti V; Rosi A
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H NMR detects different metabolic profiles in glioblastoma stem-like cells.
    Guidoni L; Ricci-Vitiani L; Rosi A; Palma A; Grande S; Luciani AM; Pelacchi F; di Martino S; Colosimo C; Biffoni M; De Maria R; Pallini R; Viti V
    NMR Biomed; 2014 Feb; 27(2):129-45. PubMed ID: 24142746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
    NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
    Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived glioblastoma stem cells respond differentially to targeted therapies.
    Kanabur P; Guo S; Simonds GR; Kelly DF; Gourdie RG; Verbridge SS; Sheng Z
    Oncotarget; 2016 Dec; 7(52):86406-86419. PubMed ID: 27863440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities.
    Spinelli C; Montermini L; Meehan B; Brisson AR; Tan S; Choi D; Nakano I; Rak J
    J Extracell Vesicles; 2018; 7(1):1490144. PubMed ID: 30034643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
    Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells.
    Rackov G; Iegiani G; Uribe D; Quezada C; Belda-Iniesta C; Escobedo-Lucea C; Silva A; Puig P; González-Rumayor V; Ayuso-Sacido Á
    Front Oncol; 2020; 10():1665. PubMed ID: 32974206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
    Nakano I
    Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
    Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
    Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
    Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
    Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
    Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
    Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
    Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.